A series of precedent-setting rulings signals that Chinese courts are being enlisted to shield workers from displacement by artificial intelligence.
Category: Regulation and Deregulation of Industry
-
China Wants A.I. to Flourish, but Not at the Expense of Jobs
The New York Times – Business: -
Tesla’s Semi Truck could Jolt the Trucking Industry
The New York Times – Business:California truckers have expressed strong interest in the Tesla Semi because it costs much less and can travel further on a charge than electric trucks sold by established manufacturers.
-
Insurers’ Delays in Approving Medical Care Persist, Despite Promises
The New York Times – Business:Doctors and patients complain that the controversial practice of prior authorization for treatment and procedures is still widespread.
-
Some Medicare Patients Can Now Get Free CBD
The New York Times – Business:The Trump administration has authorized a test program to see if the cannabis compound can ease some symptoms and reduce health care costs among older patients.
-
Rich Danker, RFK Jr.’s Top Spokesman, Resigns in Protest Over New Vaping Policy
The New York Times – Business:In a letter to President Trump, the spokesman, Rich Danker, said allowing the sale of flavored e-cigarettes would enhance their appeal to children.
-
F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure
The New York Times – Business:The agency’s top food official will step in as acting commissioner, after Dr. Makary’s tumultuous run as the nation’s top food, drug, tobacco and medical device regulator.
-
How ‘The View’ Landed at the Center of a Free Speech Battle
The New York Times – Business:The Trump administration’s focus on the show is testament to the enduring influence of an old-fashioned broadcast TV program started 29 years ago.
-
Trump Plans to Fire F.D.A. Commissioner Marty Makary
The New York Times – Business:Dr. Makary has been a supporter of the Make American Healthy Again Movement but made some enemies in the administration over vaping, the abortion pill and rejections of new drugs.
